Keywords: phase, ii, results, bb, lexipafant, british, biotech

Phase II Results With BB's Lexipafant

Article | 18 September 1995

Print This

British Biotech has completed its Phase II trial of intravenous lexipafant in patients with acute pancreatitis, and has revealed that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in